Romagnani, Sergio

Phenotypic and functional features of human Th17 cells

Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E., Filì, L., Ferri, S., Frosali, F., et al. (2007) · The Journal of Experimental Medicine

Psoriasis: Treatment and PathogenesisT-cell and B-cell Immunology

Cited by 1,861

The 3 major types of innate and adaptive cell-mediated effector immunity

Annunziato, F., Romagnani, C., & Romagnani, S. (2015) · Journal of Allergy and Clinical Immunology

IL-33, ST2, and ILC PathwaysT-cell and B-cell Immunology

Cited by 818

Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent

Mazzoni, A., Salvati, L., Maggi, L., Capone, M., Vanni, A., Spinicci, M., Mencarini, J., Caporale, R., Peruzzi, B., Antonelli, A., et al. (2020) · Journal of Clinical Investigation

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 502

CD161 is a marker of all human IL‐17‐producing T‐cell subsets and is induced by RORC

Maggi, L., Santarlasci, V., Capone, M., Peired, A., Frosali, F., Crome, S. Q., Querci, V., Fambrini, M., Liotta, F., Levings, M. K., et al. (2010) · European Journal of Immunology

Psoriasis: Treatment and PathogenesisT-cell and B-cell Immunology

Cited by 362

Type 17 T helper cells-origins, features and possible roles in rheumatic disease.

Annunziato, F., Cosmi, L., Liotta, F., Maggi, E., & Romagnani, S. (2009) · Nature Reviews Rheumatology

Psoriasis: Treatment and PathogenesisT-cell and B-cell Immunology

Cited by 212

Heterogeneity of human effector CD4+ T cells

Annunziato, F., & Romagnani, S. (2009) · Arthritis Research & Therapy

Psoriasis: Treatment and PathogenesisT-cell and B-cell Immunology

Cited by 194